Sonosite, Inc. Underwriting Agreement July 10, 2007Underwriting Agreement • July 16th, 2007 • Sonosite Inc • Surgical & medical instruments & apparatus • New York
Sonosite, Inc., a Washington corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of $200,000,000 principal amount of its 3.75% Convertible Senior Notes due 2014 (the “Firm Securities”), and, at the option of the Underwriters, up to an additional aggregate of $25,000,000 principal amount of its 3.75% Convertible Senior Notes due 2014 (the “Additional Securities”). The Firm Securities and the Additional Securities are herein referred to as the “Securities.” The Securities will be issued pursuant to a Supplemental Indenture to be dated as of July 16, 2007 (the “Indenture”) between the Company and Wells Fargo Bank, National Association (the “Trustee”). The Securities will be convertible into shares (the “Underlying Securities”) of common stock of the Company, par value $0.01 per share (the “Common Stock”), in accordance with the te
SONOSITE, INC. as Issuer and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of July 16, 2007 3.75% Convertible Senior Notes Due 2014First Supplemental Indenture • July 16th, 2007 • Sonosite Inc • Surgical & medical instruments & apparatus • New York
FIRST SUPPLEMENTAL INDENTURE dated as of July 16, 2007 (the “First Supplemental Indenture”) between SonoSite, Inc., a Washington corporation, as issuer (the “Company”), and Wells Fargo Bank, National Association, a national banking association, as trustee (the “Trustee”).
